Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With He… (NCT00002386) | Clinical Trial Compass
CompletedPhase 4
Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia
United States55 participants
Plain-language summary
The purpose of this study is to see if indinavir plus two other anti-HIV drugs affect blood clotting in HIV-positive patients with hemophilia.
Who can participate
Age range16 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria
You may be eligible for this study if you:
* Are an HIV-positive male.
* Have been diagnosed with hemophilia.
* Have been taking clotting factors for hemophilia for at least 6 months.
* Have been taking a combination of one protease inhibitor plus two other anti-HIV drugs for at least 6 months, or have never taken a protease inhibitor.
* Are at least 16 years old (consent of parent or guardian required if under 18).